Novartis Ag (NVS) Goodwill (2009 - 2026)

Novartis Ag has disclosed Goodwill across 18 years of filings, most recently posting $26.8 billion for Q2 2026.

• In Q2 2026, Goodwill rose 4.75% year-over-year to $26.8 billion; the TTM figure through Jun 2026 stood at $26.8 billion (up 4.75% YoY), while the FY2025 annual figure was $25.6 billion, up 3.28% from the prior year.
• Goodwill came in at $26.8 billion for Q2 2026 at Novartis Ag, roughly flat from $26.8 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $29.5 billion in Q2 2023 to a low of $148.0 million in Q1 2022.
• Average Goodwill over 5 years is $24.8 billion, with a median of $25.6 billion recorded in 2025.
• Year-over-year, Goodwill jumped 19819.59% in 2023 and retreated 21.77% in 2024.
• Over 5 years, Goodwill stood at $29.3 billion in 2022, then dropped by 20.34% to $23.3 billion in 2023, then climbed by 6.06% to $24.8 billion in 2024, then advanced by 3.28% to $25.6 billion in 2025, then rose by 4.69% to $26.8 billion in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $26.8 billion in Q2 2026, $26.8 billion in Q1 2026, and $25.6 billion in Q4 2025.